Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA. (Q44185305)

30 November 2017

Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA. (English)

1 reference

30 November 2017

1 reference

Ayanna S Augustus

1

1 reference

30 November 2017

Yuko Kako

series ordinal

2

1 reference

30 November 2017

Hiroaki Yagyu

series ordinal

3

1 reference

30 November 2017

Ira J Goldberg

series ordinal

4

1 reference

30 November 2017

15 October 2002

1 reference

American Journal of Physiology - Endocrinology and Metabolism

30 November 2017

1 reference

30 November 2017

284

1 reference

30 November 2017

E331-9

1 reference

30 November 2017

2

1 reference

Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles

30 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00298.2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00298.2002

Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00298.2002

Human Forearm Muscle Metabolism during Exercise II Uptake, release and oxidation of individual FFA and glycerol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00298.2002

Utilisation of triacylglycerol and non-esterified fatty acid by the working rat heart: myocardial lipid substrate preference

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00298.2002

Induced mutant mouse lines that express lipoprotein lipase in cardiac muscle, but not in skeletal muscle and adipose tissue, have normal plasma triglyceride and high-density lipoprotein-cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00298.2002

Interactions of lipoprotein lipase with the active-site inhibitor tetrahydrolipstatin (Orlistat).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00298.2002

Regulation of fatty acid oxidation in the mammalian heart in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00298.2002

Chylomicron metabolism by the isolated perfused mouse heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00298.2002

Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: direct evidence that lipoprotein lipase bridging occurs in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00298.2002

Lipoprotein lipase expression exclusively in liver. A mouse model for metabolism in the neonatal period and during cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00298.2002

Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00298.2002

Food deprivation increases post-heparin lipoprotein lipase activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00298.2002

Fatty acid homeostasis in the normoxic and ischemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00298.2002

Cardiac fatty acid uptake and transport in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00298.2002

10.1152/AJPENDO.00298.2002

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference